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Infection of Myofibers Contributes to Increased Pathogenicity during
Infection with an Epidemic Strain of Chikungunya Virus
Anjali Rohatgi,a Joseph C. Corbo,b Kristen Monte,a Stephen Higgs,c Dana L. Vanlandingham,d Gabrielle Kardon,e
Deborah J. Lenschowa,b

ABSTRACT

Chikungunya virus (CHIKV) is an alphavirus transmitted by mosquitoes that is known to cause severe arthritis and myositis in
affected patients. The ongoing epidemic began in eastern Africa in 2004 and then spread to islands of the Indian Ocean, India,
and Southeast Asia, ultimately afflicting millions. During this outbreak, more severe disease manifestations, including fatalities,
have been documented. The reasons for this change in pathogenesis are multifactorial but likely include mutations that have
arisen in the viral genome which could alter disease pathogenesis. To test this hypothesis, we used a murine model of CHIKV to
compare the disease pathogeneses of two recombinant strains of CHIKV, the first derived from the La Reunion outbreak in 2006
(LR2006 OPY1) and the second isolated from Senegal in 1983 (37997). While the two strains exhibited similar growth in mammalian cells in vitro, we observed more severe clinical disease and pathology in mice infected with the LR2006 OPY1 strain of
CHIKV, which included prolonged viremia and elevated viral titers and persistence in the muscle, resulting in devastating myonecrosis. Both CHIKV strains infected connective tissue fibroblasts of the muscle, but only the LR2006 OPY1 strain replicated
within myofibers in vivo, despite similar growth of the two strains in these cell types in vitro. However, when the 37997 strain
was administered directly into muscle, myofiber infection was comparable to that in LR2006 OPY1-infected mice. These results
indicate that differences in the ability of the strain of CHIKV to establish infection in myofibers may contribute to the increased
disease severity.
IMPORTANCE

CHIKV is an emerging pathogen that causes significant morbidity. Little is known about the pathogenesis of the disease, and this
study suggests that the ability of a recent epidemic strain to infect myofibers results in increased disease severity. Better understanding of how CHIKV causes disease contributes to the ultimate goal of creating therapeutics to alleviate the impact of this
debilitating virus.

C

hikungunya virus (CHIKV) is a mosquito-borne alphavirus
in the Togaviridae family. It was first identified in 1952 in
Tanzania and was named in the Makonde language for the painful
arthritis it causes (1). Since then, periodic outbreaks of chikungunya fever have been reported intermittently in Africa and Asia.
CHIKV was brought to attention most recently when an outbreak
began in 2004 in Kenya. In short order, the virus spread to surrounding countries and islands off the coast. In 2006, nearly 40%
of the population of La Reunion island was infected, and between
3 to 6.5 million cases are estimated to have occurred in India from
2006 to 2008 (2). Unlike previous outbreaks, which have been of
limited duration, this epidemic has continued into 2013, with
spread throughout India and into Malaysia and Thailand.
In previous outbreaks, CHIKV had behaved like the “Old
World” alphaviruses, such as Sindbis virus or Ross River virus
(RRV), with the disease characterized by abrupt high fever, incapacitating polyarthritis, and skin manifestations (3, 4). While
quite debilitating, the infection is generally self-limited and is
cleared within 2 weeks by most patients. However, a subset of
patients can develop polyarthritis and tenosynovitis that can last
for months or even years following the initial infection (5–7).
Epidemiological studies from this ongoing outbreak have also revealed more severe disease manifestations. Mortality due to
CHIKV infection was noted for the first time, with over 250 deaths
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attributable to CHIKV infection occurring during the La Reunion
epidemic (8, 9). This increased mortality was observed predominantly in elderly patients with other comorbidities. Increased susceptibility of neonates to severe infection with subsequent longterm sequelae has also been noted (8, 10). Furthermore, around
one-half of the mothers with ongoing CHIKV infection at the time
of delivery transmitted CHIKV to their offspring (11). Neonatal
infection consisted of fever, poor feeding, pain, and skin manifestations, with severe illness presenting as encephalopathy, often
resulting in long-term sequelae (11).
The reasons for the increased severity during this outbreak are
likely multifactorial and include the larger scale of the outbreak,
more thorough documentation and follow-up by the medical
community, and novel mutations that have accrued in the current
circulating strain of CHIKV. The importance of these novel mu-
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MATERIALS AND METHODS
Mice. Mice were maintained at Washington University School of Medicine in accordance with all federal and university guidelines. For mouse
studies, the principles of good laboratory animal care were adhered to in
strict accordance with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the NIH (23). The protocols were approved
by the Animal Studies Committee at Washington University. All efforts
were made to minimize suffering. C57BL/6 and alpha/beta interferon
(IFN-␣/␤) receptor 1 (IFNAR⫺/⫺) mice on the C57BL/6 background
were bred and maintained in our mouse colony. For neonatal experiments, mice were infected at 6 days of age. Litters were weight matched at
the initiation of the experiments.
Virus production. The construction of recombinant plasmids for the
LR2006 OPY1, 37997, LR2006-green fluorescent protein (GFP), and
37997-GFP strains of CHIVK has been previously described (19, 20). Recombinant viral stocks were generated from viral cDNA clones by in vitro
transcription of linearized cDNA templates followed by RNA transfection
with Lipofectamine 2000 (Invitrogen) into baby hamster kidney 21 cells
(BHK cells) as previously described (24). After 48 h, the supernatant was
collected, centrifuged, aliquoted, and stored at ⫺80°C. Titers of viral
stocks were determined by plaque assay as previously described (25). All
work with live virus was performed in a biosafety level 3 facility and followed strict guidelines established by the Environmental Health and
Safety committee at Washington University School of Medicine.
Cells. Murine embryonic fibroblasts (MEFs) were generated from
C57BL/6 or IFNAR⫺/⫺ mice and were grown in Dulbecco modified Eagle
medium (DMEM) (Mediatech) supplemented with 10% fetal bovine serum (FBS) (Sigma), 1% penicillin-streptomycin (Mediatech), 1% L-glutamine (Mediatech), and 1% HEPES (Mediatech). MEFs were used prior
to passage number 5 for these studies. Primary muscle fibroblasts were
isolated from newborn mice as previously described (26). Briefly, skeletal
muscle obtained from newborn mice was dissected and digested with
collagenase (Worthington). Cells were cultured in F12 medium (Invitrogen) with 10% FBS and 1% penicillin-streptomycin for 2 days before
replating the cells for growth curve analysis. C2C12 cells were obtained
from ATCC (ATCC CRL1772) and cultured as recommended. To obtain
myofibers, C2C12 cells were plated at 5 ⫻ 104 cells/well in 24-well plates,
differentiated into myofibers by the substitution of 2% horse serum for
FBS, and then cultured for 10 days prior to infection as described below.
Viral growth curves. MEFs, primary connective tissue fibroblasts, and
C2C12 cells were grown and/or differentiated as described above. For viral
growth curves, MEFs were plated at 1 ⫻ 105 cells/well and all other cell
types were plated at 5 ⫻ 104 cells/well in 24-well tissue culture-treated
plates and allowed 24 h to adhere. For interferon sensitivity assays, cells
were then either pretreated with IFN-␤ (PBL InterferonSource) at the
indicated dose or mock treated with medium only for 24 h. Cells were
infected at the indicated multiplicity of infection (MOI). Cells were rinsed
with DMEM with 1% FBS, after which diluted virus was added and allowed to adhere for 1 h. The virus was then aspirated and replaced with
fresh medium. At each time point, a plate was frozen at ⫺80°C and underwent three freeze-thaw cycles before titers were determined on BHK
cells by standard plaque assay.
Viral studies. Six- to nine-day-old pups were infected with between
5 ⫻ 104 and 1 ⫻ 105 PFU of the indicated recombinant CHIKV clone
(37997 or LR2006 OPY1) diluted in 15 l of phosphate-buffered saline
(PBS) and injected intradermally (i.d.) to mimic a mosquito bite, using a
Hamilton syringe and 30-gauge needle, into the left upper pectoral area.
For survival experiments, pups were monitored daily for clinical signs of
disease (including ruffling of fur, altered gait, and hind limb paralysis) and
lethality for 21 days postinfection (dpi). For viral titers, the mice were
infected as described above and the various tissues (injection site, serum,
muscle, and brain) were harvested into PBS and stored at ⫺80°C. Injection site refers to the skin and underlying connective tissue and fat at the
site of infection. Serum samples were pooled when collected, with each
sample containing sera from two mice from a single experiment. For
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tations has already been demonstrated by a recent study in which
an alanine-to-valine mutation at residue 226 in the E1 protein of
La Reunion strains of CHIKV was found to result in increased
infectivity of a new mosquito vector, Aedes albopictus, the Asian
tiger mosquito (12). The new vector is present in temperate regions and may have contributed to autochthonous outbreaks in
France and Italy, and it has potential to spread the disease in North
America as well (13–15). It is therefore also possible that some of
the novel mutations could contribute to the increased disease pathology observed during this ongoing outbreak.
To test for differences in disease pathogenesis, we used the
neonatal model of CHIKV infection. The infection of neonatal
mice recapitulates many of the clinical and histological findings of
human CHIKV infection. Infected neonatal mice exhibit significant viral dissemination to multiple tissues, develop neurological
signs of disease, and succumb to infection (16), similar to what has
been observed in patients, especially in highly susceptible neonates (11). Biopsy samples from patients that have been stained
for CHIKV antigen localize the staining to the muscle connective
tissue fibroblasts and satellite cells (17). An evaluation of CHIKV
localization following the infection of 9-day-old mice also localized CHIKV to the muscle fibroblasts, which support muscle
health, as well as myoblasts (16). Finally, while the pathogenesis of
alphavirus-induced disease is incompletely understood, the inflammatory response clearly contributes to disease. The expression of proinflammatory cytokines, including interleukin-6 (IL-6)
and IL-1␤, correlates with the severity of CHIKV-induced disease
in patients (18). In the neonatal mouse model, we observe the
induction of these proinflammatory cytokines following infection. Therefore, the infection of neonatal mice recapitulates many
of the clinical and histological findings of human CHIKV infection and provides us with a small-animal model to evaluate potential differences in disease pathogenesis between the CHIKV
recombinant clones.
To evaluate whether an epidemic strain of CHIKV differs in
disease characteristics from a past strain from a previous outbreak,
we utilized a recombinant clone of CHIKV isolated from the La
Reunion outbreak in 2006 (LR2006 OPY1) and compared this to
an earlier recombinant clone isolated from Senegal in 1983
(37997). The 37997 strain belongs to the West African clade of
CHIKV, while LR2006 belongs to the East Central South African
clade, which diverged many years ago (19, 20); the LR2006 OPY1
strain has sequence changes similar to those of other clinical isolates from the Indian Ocean outbreak (21). An earlier analysis of
these two recombinant clones found that the LR2006 OPY1 strain
showed increased infectivity of and transmission by A. albopictus,
though the two strains grow similarly in C6/36 cells derived from
A. albopictus (12, 22). We observed that despite similar in vitro
growth in various mammalian cell types, the LR2006 OPY1 strain
displayed a more severe disease phenotype, resulting in hind limb
weakness and high muscle titers in neonatal mice. While both
strains were able to infect muscle connective tissue fibroblasts
early in infection, only LR2006 OPY1 was able to infect myofibers.
However, this was not due to a difference in tropism, as both
strains were able to replicate in myoblasts and myofibers in vitro.
When 37997 was injected directly into the muscle, myofiber infection comparable to that of LR2006 OPY1 was observed. This suggests that the ability of a viral strain to establish infection in myofibers can impact the severity of infection.

Rohatgi et al.
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(MCP-1), RANTES, and interferon-stimulated gene 15 (ISG15) gene expression assays were purchased from Applied Biosystems. IFN-␤ primers
and probes were provided courtesy of Michael Diamond (Washington
University, St. Louis, MO) and are forward primer 5=-GGC TTC CAT
CAT GAA CAA CAG-3=, reverse primer 5=-GTT GAT GGA GAG GGC
TGT G-3=, and probe 5=-5/6FAM/CTG CGT TCC TGC TGT GCT TCT
C/36-TAMSp/-3=. Pan-IFN-␣ primers and probes were used as previously
reported (27).
ELISA. Mice were infected with 1 ⫻ 105 PFU i.d., and serum was
harvested at the indicated time points and stored at ⫺80°C. An IFN-␣
enzyme-linked immunosorbent assay (ELISA) kit from PBL InterferonSource was used according to the manufacturer’s instructions.
Chimeric viruses. Chimeric viruses were constructed using a method
described previously (28). Briefly, the E2 region of each strain was amplified using the forward primer 5=-AATGTCTATAAAGCCACAAGAC-3=
and the reverse primer 5=-ACGTTGACAGACTCTGAGAA-3=. The segments were gel extracted and used as primers for the next PCR with the
opposite strain with the QuikChange II XL mutagenesis kit (Agilent). The
reaction mix then underwent an initial incubation for 1 min at 98°C,
followed by 18 cycles of 98°C for 30s, 60°C for 30s, and 72°C for 8 min and
a final extension of 72°C for 10 min. Clones were sequenced using the
forward and reverse primers. Viruses were then generated as described in
“Virus production” above.
Statistical analysis. All data were analyzed using the Prism software
(GraphPad Software, San Diego, CA). Survival data were analyzed using
Gehan-Breslow-Wilcoxon test, with death as the primary variable. Acutetiter data and cytokine data were analyzed using the Mann-Whitney test.
Errors bars in figures represent the standard error of the mean.

RESULTS

CHIKV strains 37997 and LR2006 OPY1 display similar growth
and sensitivity to an IFN-␤-induced antiviral state in primary
MEFs. A previous comparison of the sequences of the 37997 and
the LR2006 OPY1 strains of CHIKV revealed 162 amino acid differences between these two strains (22). Since these differences
could impact the ability of these viruses to replicate, we first
wanted to evaluate their growth in mammalian cells prior to evaluating potential differences in pathogenesis. Both BHK cells and
MEFs were infected with the two strains of CHIKV at a low MOI,
and viral growth over time was analyzed. Both the LR2006 OPY1
and the 37997 strains of virus grew with similar kinetics in BHK
cells (data not shown). We also observed no difference in the viral
growth rate or in the peak viral titers achieved in MEFs infected
with either strain at any of the time points analyzed (Fig. 1A).
Previous studies with other alphaviruses have shown that mutations controlling the sensitivity of a virus to type I interferons
could impact its in vivo pathogenesis (29, 30). Mutations mapped
to the 5= nontranslated region and the nsP1 and nsP2 genes in
Sindbis virus have been found to affect interferon sensitivity (29,
30). There are residue differences in these genes between the
LR2006 OPY1 and 37997 strains (22). Therefore, we next tested
whether the two strains of CHIKV displayed similar in vitro sensitivities to type I IFNs. C57BL/6 MEFs were either mock treated
or treated for 24 h prior to infection with IFN-␤ at a dose that
would induce an antiviral response and partially inhibit viral replication. The cells were then infected, and viral growth was monitored at several time points postinfection. As seen in Fig. 1B
(dashed lines), IFN pretreatment was able to equivalently inhibit
both the LR2006 OPY1 and the 37997 strains of CHIKV. We also
observed a similar increase in replication of the two CHIKV
strains following the infection of IFNAR⫺/⫺ MEFs, with the virus
growing to titers that were nearly 100-fold higher than in B6 MEFs
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muscle titers, the hind limb ipsilateral to the site of infection was skinned
and the hamstring was collected. For the analysis of viral loads, the samples were homogenized with 100 l of 1.0-mm-diameter zirconia-silica
beads using a MagnaLyzer (Roche) by alternating two pulses of 7,000 rpm
for 30 s each, with chilling on ice for 30 s. The homogenates were serially
diluted, and titers were determined by plaque assay on BHK cells. For
serum collection, pups were bled at the designated time postinfection into
BD Serum Separator tubes. These were spun for 9 min at 12,000 ⫻ g and
then frozen at ⫺80°C until their titers were determined.
Histopathology. Six-day-old pups were infected i.d. with 5 ⫻ 104 PFU
of either CHIKV recombinant clone or were mock infected i.d. with PBS
in the left upper pectoral area. Mice were sacrificed at the indicated day
postinfection, and the hind limb and brain were fixed with 10% formalin
for 48 h at room temperature and then rinsed with PBS for 15 min and
stored in 70% ethanol at 4°C until being submitted for embedding in
paraffin blocks and sectioning. The sections were stained with hematoxylin and eosin to examine for histopathology. Embedding, sectioning, and
staining were performed by the Anatomic and Molecular Pathology Histology Core at Washington University in St. Louis. All slides were evaluated and scored blindly by one of the authors (J.C.C.) for the presence of
histopathological changes consistent with mengoencephalitis in the brain
samples and for histological changes within the muscle. Changes in the
muscle were scored as follows: 0, normal; 1, predominantly normal tissue,
only minimal chronic inflammatory infiltrates and some regenerative
fibers; 2, focal, mild chronic inflammatory infiltrates and some degeneration/regeneration; 3, mild myonecrosis with chronic inflammatory infiltrates and degeneration/regeneration; 4, moderate myonecrosis with
chronic inflammatory infiltrates and degeneration/regeneration; and 5,
severe myonecrosis with chronic inflammatory infiltrates and degeneration/regeneration.
Cytokine/chemokine analysis. Sera were harvested from infected
mice at the indicated time points and stored at ⫺80°C for analysis. Serum
cytokine levels were measured using Luminex technology with the Bioplex Pro mouse cytokine 23-plex assay (Bio-Rad).
Immunofluorescence. For immunofluorescence experiments, the
mice were infected as described above, but we utilized recombinant clones
for the 37997 and LR2006 OPY1 strains expressing green fluorescent protein (GFP) (19). For intradermal infections, 1 ⫻ 105 PFU of either GFP
strain was injected into the skin of the upper left chest of 6-day-old pups.
For intramuscular (i.m.) injections, 2.5 ⫻ 104 PFU of either the GFPexpressing, or parental recombinant strains was injected directly into the
left hamstrings of 6-day-old pups. Tissue was harvested from the mice at
the indicated times and fixed in 4% paraformaldehyde for 24 h at 4°C. It
was then rinsed with PBS for 24 h and allowed to equilibrate in 30%
sucrose for 2 h before embedding in OCT. Sections were cut using a
cryostat and blocked with 5% normal goat serum (Sigma). Sections were
stained with an anti-collagen IV antibody (Abcam) and with DAPI (4=,6=diamidino-2-phenylindole) (Vector Laboratories). The slides were developed with a donkey anti-rabbit 546 secondary antibody using Alexa Fluor
(Invitrogen).
Quantification of histology. Photographs were taken using a Nikon
Eclipse 80i microscope and processed with Metamorph software (Molecular Devices). To quantify, 6 high-power (⫻40 or ⫻20) fields (hpf) were
taken per section, with a single section per mouse. For i.m. injections,
GFP-positive (GFP⫹) and GFP-negative fibers were counted in each hpf,
and the percent positive cells was calculated. For i.d. injections, only
GFP⫹ cells per hpf were counted. The mean and standard error of the
mean (SEM) of all high-power fields per sections were used to calculate
significance.
RT-PCR. Mice were infected with 1 ⫻ 105 PFU i.d. Tissues were excised and flash frozen in liquid nitrogen. Tissues were homogenized using
the MagnaLyzer (Roche), and RNA was extracted using the RNeasy
fibrous tissue kit (Qiagen). RNA was used to run real-time PCR (RT-PCR)
on the infected tissues, normalizing to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (IDT). Monocyte chemoattractant protein 1
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(Fig. 1C). As expected, pretreatment of these cells had no impact
on CHIKV replication. Together, these results indicate that the
LR2006 OPY1 and the 37997 recombinant clones of CHIKV displayed similar growth kinetics in mammalian cells and similar
sensitivities to IFN in vitro.
The LR2006 OPY1 strain of CHIKV induces more severe disease than the 37997 strain of CHIKV. Next, we evaluated the
pathogeneses of these two clones using a neonatal murine model
of CHIKV infection. In this model, the infection of wild-type
(WT) mice less than 10 days of age results in the development of a
disseminated infection with significant lethality (16, 31). We infected 6-day-old C57BL/6 pups i.d. in the upper left chest with 5 ⫻
104 PFU of either the LR2006 OPY1 or the 37997 strain of CHIKV.
Infection with either strain of CHIKV resulted in significant
lethality with a similar median onset of lethality of 10 days for both
viruses, with 54% of the LR2006 OPY1-infected pups and 68% of
the 37997-infected pups succumbing to infection (Fig. 2A). However, despite the similarity in lethality induced by both strains of
CHIKV, we observed more severe clinical signs of disease in the
LR2006 OPY1-infected pups than in the 37997-infected mice.
While mice infected with either strain of CHIKV displayed ruffled
fur, sluggishness, and altered gait, the LR2006 OPY1-infected
mice often developed hind limb weakness and paralysis, which
were rarely seen in the 37997-infected mice (data not shown). This
severe weakness was first observed at 7 days postinfection (dpi)
and lasted throughout the course of infection in surviving mice.
To further investigate the differences in the clinical courses
induced by the two strains, we next evaluated viral dissemination
and replication of the two clones in six-day-old mice at different
times postinfection. An analysis of the injection site, which included the skin and underlying connective tissue, revealed similar
viral loads at all of the time points analyzed, with peak titers obtained at 1 dpi and a steady decrease in viral replication until 9 dpi,
when replicating virus was no longer detected (Fig. 2B). It has
been previously reported that in the neonatal model of CHIKV
infection, mice develop viremia, resulting in viral dissemination
to multiple tissues. Mice infected with either strain of CHIKV
developed viremia, with similar viral levels detected in the LR2006
OPY1- and the 37997-infected mice at both 1 and 3 dpi (Fig. 2C).
However, mice infected with the 37997 strain cleared the virus
from the serum by 4 dpi. In contrast, mice infected with the
LR2006 OPY1 strain maintained persistent viremia until 7 dpi,
when serum viremia was no longer detected.
The hind limb weakness and ataxic gait that we observed in the
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LR2006 OPY1-infected mice could be due to CHIKV infection
impacting either the central nervous systems or the muscles, or
both, of these mice. Therefore, we evaluated viral loads in both the
brains and the muscles of mice infected with either the LR2006
OPY1 or the 37997 strain. While we did observe an increase in
viral titers in the brains of the LR2006 OPY1-infected mice at 3
and 4 dpi, by 5 dpi similar titers were observed in mice infected
with either CHIKV strain, and both strains were cleared by 12 dpi
in surviving mice (Fig. 2D). Furthermore, histological evaluation
of the brains from these mice at the various times postinfection
revealed no significant pathology induced by either strain of
CHIKV (data not shown). In contrast to the case for the brain, an
analysis of viral titers in the muscle revealed a striking difference
between the two strains. We found that infection with either strain
of CHIKV resulted in detectable viral titers in the muscle as early
as 1 dpi (Fig. 2E). Consistent with our clinical observations, however, the LR2006 OPY1-infected mice had significantly greater
viral burdens in their muscles. By 3 dpi the mice infected with the
LR2006 OPY1 strain of CHIKV displayed greater than 100-fold
more virus in their muscles than those infected with the 37997
strain, even though serum viral loads were similar for the two
strains at this time point. The increased viral burden observed in
the muscles of the LR2006-infected mice persisted until at least 9
dpi, with the LR2006 OPY1-infected mice having between 3- and
4-log-higher viral titers in their muscle (Fig. 2E). Mice infected
with the 37997 strain had peak replication at 5 dpi with a mean
titer of 3.0 ⫻ 104 PFU/ml, while the LR2006 OPY1 strain peaked at
6 dpi with a mean titer of 6.17 ⫻ 107 PFU/ml (Fig. 2E). While the
37997 strain was largely cleared from the muscle by 9 dpi, mice
infected with the LR2006 OPY1 strain continued to have greater
than 10,000-fold more virus, even at 9 dpi. Even increasing the
infecting dose of 37997 to 20 times the dose (2 ⫻ 106 PFU i.d.) did
not result in an increase in viral loads detected in the muscles of
the infected mice (data not shown). To determine if the adaptive
immune response played a role in clearing the viral infection from
the muscle, we also infected Rag⫺/⫺ mice with either strain of
CHIKV and observed no differences in viral loads compared to
those in WT mice (data not shown). Therefore, consistent with
the hind limb weakness observed in the mice infected with the
LR2006 OPY1 strain of CHIKV, we observed increased peak viral
loads and prolonged replication in the muscles of mice infected
with the LR2006 OPY1 strain.
LR2006 and 37997 elicit similar serum type I IFN and proinflammatory cytokine and chemokine responses during the
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FIG 1 Recombinant CHIKV strains LR2006 OPY1 and 37997 display similar growth characteristics in vitro. (A) WT MEFs were infected at an MOI of 0.05 for
1 h and analyzed for titer by plaque assay at several time points postinfection. (B and C) WT MEFs (B) or IFNAR⫺/⫺ MEFs (C) were pretreated with 8 U/ml of
IFN-␤ for 24 h before infection and then infected at an MOI of 0.05 for 1 h, and titers were determined by plaque assay as for panel A. Growth curves were
determined in two independent experiments, each in duplicate.

Rohatgi et al.

OPY1 or 37997 CHIKV strain. (A) Infected mice were monitored for clinical signs of disease and death each day until 21 days postinfection. (B to E) Infected mice
were harvested at the indicated time points; injection site (B), serum (C), brain (D), and distal hind limb muscle (E) were collected, and titers were determined
by plaque assay (n ⫽ 5 to 8 pups per group per time point, except at 12 dpi, where n ⫽ 4 pups per time point). The dashed lines indicate the limit of detection
for the assay. Significance for survival was evaluated by both the log rank and the Gehan-Breslow-Wilcoxon tests. Statistical significance for panels B to E was
evaluated with the Mann-Whitney test. *, P ⫽ 0.01 to 0.05; **, P ⫽ 0.001 to 0.01; ***, P ⬍ 0.001; N.S., not significant.

course of infection. One explanation for the dramatic difference
in viral titers could be altered production of type I IFNs by the two
viruses or perhaps differential antagonism of this response. To
begin to assess this possibility we first evaluated whether there was
a difference in the systemic induction of type I IFNs by the LR2006
OPY1 and the 37997 strains of CHIV. Mice were infected with
either the LR2006 OPY1 or the 37997 strain of CHIKV, and serum
IFN-␣ levels were measured at various time postinfection (Fig.
3A). We detected very little IFN at 8 h postinfection. Levels peaked
at 16 h postinfection and slowly diminished during the next 48 h.
However, we observed no differences in the levels of systemic
IFN-␣ induced by either viral strain. Since we observed the largest
differences in viral loads in the muscles of infected mice, we also
evaluated the type I IFN response in the muscles of mice infected
with either strain of CHIKV. RT-PCR was used to measure the
levels of IFN-␤, IFN-␣, or ISG15 in the hind limb muscle at various times postinfection (Fig. 3B). While the expression of all three
was increased compared to levels in mock-infected mice, there
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was no difference in the induction of IFN-␣, IFN-␤, or ISG15
between the different CHIVK strains. Based upon this analysis, it
does not appear that the differences in disease pathogenesis seen in
the LR2006 OPY1 and the 37997 strains of CHIKV are due to
differences in the induction of type I interferon.
We have previously seen that neonatal mice infected with
CHIKV develop a systemic inflammatory response (25). Furthermore, in a neonatal model of Sindbis virus infection, this systemic
inflammatory cytokine response likely contributes to the lethality
(32). We therefore next determined if there was a difference in the
cytokines induced by either the 37997 or LR2006 OPY1 strain of
CHIKV that may account for the differences in pathogenesis that
we observed. We analyzed 23 cytokines and chemokines in the
sera of infected mice at 1, 3, 5, and 7 dpi. As previously observed,
several cytokines were induced by CHIKV infection, including
IL-1␣, IL-1␤, IL-6, IL-10, and granulocyte colony-stimulating
factor (G-CSF) (Fig. 3C). Both CHIKV strains induced elevated
levels of IL-1␤, IL-6, and RANTES, cytokines found to be associ-
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FIG 2 LR2006 OPY1 achieves higher muscle titers and persistence in the serum. Pups were infected i.d. at 6 days of age with 5 ⫻ 104 PFU of either the LR2006

CHIKV Myoﬁber Infection in Mice

with 5 ⫻ 104 PFU of either CHIKV strain or mock treated with PBS i.d. (A) Sera were collected from infected mice at several hours postinfection, and IFN-␣ levels
were measured by ELISA. The IFN-␣ level in mock-infected mice was 8.37 pg/ml. (B and D) Mice were infected with 1 ⫻ 105 PFU of either CHIKV strain. RNA
was extracted from hind limb muscle, and RT-PCR was performed. Samples were normalized to GAPDH. The dashed lines indicate RNA levels in mock-infected
mice. (C) Sera were collected at the indicated times and analyzed using a Bioplex Pro mouse 23-plex array. The dashed lines indicate the level of cytokine or
chemokine in mock-infected samples. n ⫽ 4 per time point. The results did not reach statistical significance at any time points analyzed.

ated with severe disease in human patients afflicted with CHIKV
(18). Surprisingly, despite the increased viral loads detected in the
LR2006 OPY1-infected mice during the course of viral infection,
we observed no significant difference in the cytokine levels between
the strains at any time point we analyzed. We did observe a trend
toward an increase in several chemokines, including KC, MCP-1,
MIP-1␣, MIP-1␤, and RANTES, at 1 dpi in mice infected with the
37997 strain of CHIKV (Fig. 3C), although these differences did not
reach statistical significance. To determine whether elevations in
these chemokines were also present in the muscle, where we observed
the differences in viral titers, we analyzed the hind limb muscle for
expression of MCP-1 and RANTES RNAs by RT-PCR (Fig. 3D).
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RNA levels of both chemokines were elevated over levels in mockinfected mice as early as 1 dpi. However, we observed no differences
in the induction of either MCP-1 or RANTES RNA between the two
strains of CHIKV. At 7 dpi, the RNA levels of both chemokines were
further elevated, with mice infected with LR2006 expressing levels of
MCP-1 and RANTES RNAs similar to those in mice infected with the
37997 strain, despite the increased viral burden present in these mice
at this time (Fig. 3D). Together, these results indicate that both the
37997 and the LR2006 OPY1 strains of CHIKV induce a systemic
cytokine and chemokine response in this neonatal model; however,
no significant differences in the responses induced by the two viral
strains were noted.
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FIG 3 Similar type I interferon and proinflammatory cytokine and chemokine profiles are induced by both strains of CHIKV. Six-day-old pups were infected
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with PBS. The hind limb was isolated on the indicated days postinfection and fixed in 10% formalin for 48 h. Sections were submitted for embedding, sectioning,
and staining. (A) The pathology of each sample was scored by a pathologist on a scale of 0 to 5 as described in Materials and Methods. Representative H&E-stained
sections at several days postinfection at a magnification of ⫻40 are shown, with the pathological score indicated in parentheses. (B) Graphical representation of
the scores of all of the histological sections. *, P ⫽ 0.01 to 0.05.

The LR2006 OPY1 strain of CHIKV infects myofibers and
results in greater hind limb muscle damage than the 37997
strain of CHIKV. To further characterize the disease induced by
these two CHIKV strains, we next performed a histological analysis of the muscles of infected mice. Muscle from the hind limb
distal to the site of infection was collected at various times postinfection and stained with hematoxylin and eosin (H&E). These
slides were evaluated by a pathologist in a blinded fashion. Muscle
sections were given a severity score from 0 (normal) to 5 (most
severe) as described in Materials and Methods. An analysis of the
muscles from CHIKV-infected mice revealed significant pathological changes (Fig. 4A and B). In mice infected with the 37997
strain, we observed focal areas of myositis and necrosis, with the
majority of the muscle being largely undamaged. The peak damage seen was at 9 dpi for 37997-infected mice (Fig. 4B). Consistent
with the profound muscle weakness observed clinically and the
increased viral titers, muscle from mice infected with the LR2006
OPY1 strain displayed widespread destruction beginning at 5 dpi
and lasting until at least 12 dpi, with peak damage occurring at 12
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dpi (Fig. 4A and B). In these samples there were dense inflammatory infiltrates accompanying massive myonecrosis (mean
score ⫽ 5 at 12 dpi) (Fig. 4A). Therefore, these histological data
support the clinical findings that the LR2006 strain of CHIKV
induces more severe muscle disease in these mice.
To further evaluate the differences seen in the muscles of these
mice, we next determined if there were differences in viral tropism
between the two strains. Previous work has shown that CHIKV
replicates in the connective tissue fibroblasts and myoblasts in
both mice and humans (16). While other studies have noted myofiber necrosis and attributed this to infection of those fibers by
CHIKV, previous studies have not detected infection of the myofibers (33). We utilized recombinant CHIKV strains in which GFP
expression was driven by a subgenomic promoter in either the
37997 or LR2006 OPY1 backbone. When these viruses are utilized,
only cells that harbor active CHIKV infection will express GFP.
Mice were infected i.d. with either the 37997-GFP- or LR2006GFP-expressing CHIKV strain, and at different times postinfection the hind limb muscle was evaluated by immunofluorescence.
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FIG 4 The LR2006 OPY1 strain induces dramatic myositis and necrosis. Six-day-old pups were infected with 5 ⫻ 104 PFU of CHIKV i.d. or were mock treated

CHIKV Myoﬁber Infection in Mice

OPY1-GFP i.d. at a dose of 5 ⫻ 104 PFU. Muscle from the hind limb was stained for collagen IV (red), GFP (green), or nuclei (blue). (A) Top panels, muscle
harvested at 3 dpi (magnification, ⫻40); bottom panels, muscle harvested at 7 dpi (magnification, ⫻20). (B) Connective tissue fibroblasts were counted in ⫻40
high-power fields at 3 dpi. (C) Myofibers per ⫻20 high-power field at 7 dpi. Scale bars, 100 m.

Similar to what has been previously reported, we detected GFP
staining in the connective tissue fibroblasts surrounding the muscle fibers following infection with either the LR2006 or 37997
strain of CHIKV (Fig. 5A, top panels). Staining was detected as
early as 3 days postinfection and increased throughout the course
of infection until myofibers were destroyed. Quantification of
GFP⫹ fibroblasts revealed that similar quantities of cells were infected following infection with either strain of CHIKV (Fig. 5B).
Surprisingly, in mice infected with LR2006 OPY1, we also detected
GFP⫹ staining of the myofibers, particularly at late time points
after infection, although GFP⫹ fibers could be seen as early as 3
dpi. In contrast, there was almost a complete absence of GFP⫹
myofibers in the hind limbs of mice infected with 37997-GFP (Fig.
5A, bottom panels, and 5C). These data suggest that the ability of
the LR2006 OPY1 strain to gain access to the myofibers and establish infection results in increased viral loads in the muscle and
increased muscle damage and likely contributes to the increased
pathogenicity of this CHIKV strain.
During i.m. injection, both strains are able to infect myofibers. The inability of the 37997 strain to infect the myofibers following an intradermal infection could be due to an inability of the
virus to directly infect the myoblasts/myofibers, an inability to
grow in the myoblasts, or difficulty in gaining access to this compartment. To test these possibilities, we first evaluated the abilities
of the LR2006 OPY1 and 37997 strains to infect and replicate in
primary connective tissue fibroblasts and in myoblasts and myofibers. Primary muscle connective tissue fibroblasts were isolated
from neonatal mice and infected with either strain of CHIKV at an
MOI of 0.05. Viral growth was assessed at various times postinfection. The two strains grew at similar rates and reached comparable
peak titers after 48 h postinfection (Fig. 6A). This supported our in
vivo observation that both strains infected and replicated within
the connective tissue fibroblast compartment (Fig. 5A and B). We
next evaluated the abilities of the LR2006 OPY1 and 37997 strains
to infect and replicate within myoblasts and myofibers. We first
used the C2C12 myoblast cell line to assess growth in vitro. Both
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CHIKV strains were able to infect the C2C12 cells, and an analysis
of viral growth revealed that the two strains displayed similar
growth kinetics (Fig. 6B). Next, myoblasts were differentiated into
myofibers, forming a mixed culture of both myoblasts and myofibers. They were also infected with a low MOI, which produced
comparable growth of the strains (Fig. 6C). These results suggest
that both viral strains have the ability to infect connective tissue
fibroblasts, myoblasts, and myofibers. Furthermore, it appears
that the strains display similar growth characteristics in vitro.
Therefore, it does not appear that the 37997 strain cannot infect
and/or replicate in the myoblasts but rather appears that this viral
strain may not be able to gain access to this compartment in vivo.
To determine whether the difference in viral replication was
due to the inability of 37997 to infect myofibers in vivo, intramuscular injections were performed by injecting 2.5 ⫻ 104 PFU directly into the left hamstrings of six-day-old mice. Hind limb
muscle from the site of injection was collected and stained by
immunofluorescence. In contrast to the intradermal infection,
following the direct intramuscular administration of virus, both
37997-GFP and LR2006-GFP were able to infect myofibers, as
shown at 3 dpi (Fig. 6D), and the numbers of GFP⫹ myofibers
were similar for the two viral strains (Fig. 6E). At later time points,
massive tissue destruction was seen in mice infected by either
strain, and few GFP⫹ myofibers remained (data not shown). This
finding was further supported by an analysis of viral loads in the
muscle. Mice were infected with the parental strains of LR2006
OPY1 and 37997, which lack GFP, and viral titers in the infected
muscle were analyzed at different times postinfection. Following
direct inoculation, the two strains reached similar viral titers, with
only a 3.54-fold increase in titers in the LR2006 OPY1- versus the
37997-infected muscle, compared to the 1,000-fold difference
seen during i.d. administration (Fig. 6F). Following direct inoculation, the 37997 strain reached peak titers of 6.77 ⫻ 105 PFU/ml,
much higher than its peak viral load following administration by
the i.d. route, despite using a lower inoculating dose of 2.5 ⫻ 104
PFU (Fig. 6F). The ability of the 37997 strain to replicate to high
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FIG 5 Intradermal infection results in infection of myofibers by LR2006 OPY1 but not by 37997. Mice were infected with either 37997-GFP or LR2006
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myofibers (C) were infected with either LR2006 OPY1 or 37997 at an MOI of 0.05, and titers were determined at various times postinfection by plaque assay. (D
and E) Mice were infected in the hind limb with 2.5 ⫻ 104 PFU LR2006 OPY1-GFP or 37997-GFP and sacrificed at 3 days postinfection. (D) Frozen sections of
hind limb muscle was stained for collagen IV (red), GFP (green), and nuclei (blue). Scale bar, 100 m. (E) Quantification of GFP⫹ myofibers per high-power
field. (F and G) Mice were infected in the hind limb with the parental strains at 5 ⫻ 104 PFU; muscles ipsilateral (F) and contralateral (G) to the site of infection
were harvested at the indicated days, and titers were determined by plaque assay. *, P ⫽ 0.01 to 0.05; ** P ⫽ 0.001 to 0.01; *** P ⬍ 0.001.

viral titers following direct i.m. inoculation indicates that the two
viral strains display similar fitness once they gain access to the
muscle fiber compartment. During the course of these direct intramuscular infections, we once again noted that the contralateral
legs of the mice infected with the LR2006 OPY1 strain of CHIKV
developed severe weakness, while in the mice infected with the
37997 strain of CHIKV, we did not detect contralateral leg weakness. When titers in the contralateral legs were determined, we
found that similar to the case for the i.d. route of infection, the
LR2006 OPY1-infected mice achieved significantly higher viral
titers in their contralateral legs than the titers obtained in the
37997-infected mice, with viral titers reaching 5.5 ⫻ 106 PFU/ml
in the LR2006 OPY1-infected mice at 5 dpi, compared to titers of
only 1.5 ⫻ 104 PFU/ml in the 37997-infected mice (Fig. 6G). Thus,
injecting virus at a different location, in this case directly into the
muscle, does not alter its ability to spread throughout the host.
Taken together, these results demonstrate that both the LR2006
OPY1 and the 37997 strains of CHIKV have the ability to replicate
within the primary cells of the muscle, namely, the connective
tissue fibroblasts and the myoblasts when access is provided. The
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differences in pathogenesis that we have seen in our model appear
to reflect the ability of the LR2006 OPY1 strain to access the myoblast/myofiber niche, which it can do following either i.d. or i.m.
inoculation. In contrast, the 37997 strain of CHIKV, while able to
establish viremia and infect the connective tissue fibroblasts, fails
to establish a robust infection of the myoblasts/myofibers unless it
is provided direct access via i.m. inoculation. This results in decreased viral loads and diminished muscle damage.
DISCUSSION

The ongoing epidemic of CHIKV infection has highlighted the
need for a better understanding of the pathogenesis of this reemerging pathogen. The dominant disease presentation seen during this outbreak consists of fever, rash, and arthritis, as in past
outbreaks. However, new reports suggest increased disease severity, including neurological symptoms and mortality that had not
previously been seen in CHIKV outbreaks. The reasons for altered
pathogenesis are multifactorial and include the large scale of the
outbreak, better reporting of CHIKV cases, and accrual of viral
mutations.
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FIG 6 Both strains can infect muscle when given intramuscularly. (A to C) Primary muscle fibroblasts (A), C2C12 myoblasts (B), and differentiated C2C12
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tions in the LR strain could result in increased receptor binding
and/or replication within myoblasts or myofibers. However, our
in vitro studies demonstrated that both strains were able to infect
connective tissue fibroblasts, myoblasts, and myofibers, and the
viruses grew with similar kinetics and to similar titers (Fig. 6).
Furthermore, the administration of the 37997 strain directly into
the muscle resulted in myofiber infection and dramatically reduced the differences in viral titers seen between the two strains
(Fig. 6). Interestingly, while direct i.m. administration of the two
strains equalized the viral loads within the injected muscle and
allowed for 37997 to infect the myofibers, spread of the virus to the
contralateral muscle was more efficient for the LR2006 strain,
once again resulting in viral loads that were greater than 100-fold
higher than those seen with the 37997 strain (Fig. 6). These data
suggest that the LR2006 OPY1 strain may have an increased ability
to access myofibers.
Previous studies evaluating the ability of gene therapy viral
vectors, such as herpes simplex virus 1 (HSV-1) and adenoviruses,
to infect skeletal muscle have shown that the basal lamina can
function as a physical barrier to limit myofiber infection in adult
muscle. Intact skeletal muscle was not permissive to HSV-1 infection of myofibers, but isolated myofibers cultured in vitro could be
infected (36). The disruption of the basal lamina through the utilization of genetically defective mice (dy/dy) which have abnormal
basal lamina synthesis allowed for myofiber infection in vivo (37).
One potential explanation for the differential infection of myofibers with our viruses is that during the course of the LR2006 OPY1
infection, there is an alteration in the production of cytokines or
proteases that can damage the basal lamina surrounding the muscle fibers, allowing the LR2006 OPY1 strain to establish infection.
Proinflammatory cytokines and chemokines are induced in animal models of CHIKV, and in human studies elevated levels of
IL-6, IL-1␤, and RANTES have been associated with more severe
disease manifestations (18). Infection with either the LR2006
OPY1 or the 37997 strain of CHIKV did induce a proinflammatory cytokine and chemokine response; however, despite the prolonged serum viremia following LR2006 OPY1 infection, no significant differences were observed between the two strains during
the course of infection (Fig. 3). We also did not observe a difference in the induction of type I IFNs either systemically or within
the muscle itself. While the levels of IFN did not differ, it is still
possible that there is differential induction of ISGs by these two
strains that contributes to differential control of viral replication
within the muscle fiber. A limited analysis of ISGs has not revealed
any differential expression within the muscle; however, a more
complete analysis is required to fully rule out this possibility. Alternatively, within the context of the intact muscle architecture,
differential induction in the expression of receptors for CHIKV on
myoblasts or myofibers could account for differences in infectivity. Until the CHIKV receptor is identified, the latter hypothesis
cannot be formally tested. Whether the prolonged serum viremia
we observed during the LR2006 OPY1 infection also contributes
to the myofiber infection by allowing the LR2006 OPY1 virus to
reach higher concentrations along the basal lamina is unknown.
However, the prolonged viremia cannot account for the entire
muscle phenotype, as LR2006 OPY1-infected mice already have
high titers at 3 dpi, when both strains cause similar serum viremia
(Fig. 2).
Little is known about the viral determinants that regulate
CHIKV-induced disease, in particular its ability to target the mus-
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In this study, we compared the pathogeneses of two different
CHIKV strains, one isolated during the La Reunion outbreak in
2006 and another isolated from Senegal in 1983. Importantly,
both viruses utilized in these studies were generated from recombinant clones to minimize viral heterogeneity. The clones were
not mouse adapted and represent viruses that were actively circulating when isolated. Neonatal mice infected with the La Reunion
recombinant strain (LR2006 OPY1) developed more severe disease, with progressive hind limb weakness and severe myonecrosis, than those infected with the Senegal strain (37997). 37997 and
another strain from the 2006 outbreak (DHS-4263) were also
compared in a macaque model, where slightly elevated viremia
was seen with the 37997 strain (33). Mild muscle fiber necrosis was
also seen in several animals, but muscle titers or pathology during
acute infection was not determined (33). In the murine arthritis
model, more severe joint swelling was seen in mice infected with
the LR2006 OPY1 strain than in those infected with an Asian isolate from the 1960s (34). Additional studies that carefully evaluate
viral pathogenesis and correlate this with myofiber infection will
be important to perform to try to identify the viral determinants
contributing to this phenotype.
The most striking difference in the disease induced by each
strain was the very high muscle titer in the mice infected with
LR2006 OPY1, which resulted in severe myonecrosis (Fig. 2E and
4). Both strains are able to spread from the site of infection and
establish infection in the distal muscle by infecting connective
tissue fibroblasts early in infection. CHIKV has been shown to
infect this cell type in murine models and in human biopsy specimens (16). However, as early as 3 dpi, when viral loads in the
serum were similar for the two strains, mice infected with the
LR2006 OPY1 strain had viral titers within their hind limb muscles that were 1,000-fold greater than those observed in the 37997infected mice. This increased viral load persisted until at least 9
dpi. Most strikingly, this increase in viral replication correlated
with the ability of the LR2006 OPY1 strain, but not the 37997
strain, to infect the myofibers within the muscle.
There are several hypotheses that could explain the difference
in behavior between the 37997 and LR2006 OPY1 strains. These
include differences in viral fitness, viral tropism, and access to
myofibers. A recent study of Ross River virus identified a single
amino acid change within the E2 protein (Y18H) that resulted in a
dramatic reduction in muscle titers and pathology. This switch to
histidine resulted in a decrease in the fitness of this virus in mammalian cells, resulting in reduced replication in both murine and
human cells but an increased ability to replicate in mosquito cells
(35). An alignment of the E2 proteins from the LR2006 OPY1 and
37997 strains revealed that both have a histidine at this position.
Furthermore, while the LR2006 strain does display an increase in
viral replication within the muscle and induces more damage, we
have not observed differences in viral fitness. Similar replication of
the two strains was observed in several mammalian cell types,
including BHK cells, MEFs, and connective tissue fibroblasts (Fig.
1 and 6 and data not shown), suggesting that the fitness of the virus
does not explain our in vivo phenotypes.
Previous to this study, direct infection of myofibers by CHIKV
had not been shown, though evidence of myofiber fragmentation
and necrosis has been reported (33). Since we observed the infection of myofibers following i.d. administration of the LR2006
OPY1 strain but not the 37997 strain, differences in cellular
tropism could also contribute to the altered pathogenesis. Muta-
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